Preparation of an Injectable Doxorubicin Surface Modified Cellulose Nanofiber Gel and Evaluation of Its Anti-Tumor and Anti-Metastasis Activity in Melanoma

(2018) Preparation of an Injectable Doxorubicin Surface Modified Cellulose Nanofiber Gel and Evaluation of Its Anti-Tumor and Anti-Metastasis Activity in Melanoma. Biotechnology Progress. pp. 537-545. ISSN 8756-7938

Full text not available from this repository.

Official URL: WOS:000430490800025

Abstract

Cellulose nanofibers (Cel-NFs) gel can be considered as a useful drug carrier because of its biocompatibility, high specific surface area, and high loading capacity of drugs. Injectable Cel-NFs gel could deliver doxorubicin (DOX) for localized chemotherapy of melanoma and suppress melanoma cells migration because of the physical barrier property of Cel-NFs. We prepared DOX surface modified Cel-NFs (DOX-Cel-NFs) gel by the electrostatic attachment of DOX molecules on the surface of Cel-NFs. The increase in the zeta potential of nanofibers and the changes in the FTIR spectra of DOX-Cel-NFs compared to Cel-NFs proved this attachment. DOX-Cel-NFs showed nano-fibrous structure with an average diameter of 22.32 +/- 10.66 nm after analyzing using field emission scanning electron microscopy. The suitable injectability of DOX-Cel-NFs gel verified its promising application for the localized chemotherapy. DOX-Cel-NFs gel exhibited a sustained drug release manner. The cytotoxicity results showed that DOX-Cel-NFs were more cytotoxic against melanoma cancer cells than the free DOX during 48 h incubation period. Moreover, DOX-Cel-NFs gel can suppress the melanoma cancer cells migration efficiently. Thus our results emphasize the potential of DOX-Cel-NFs gel as a chemotherapeutic agent for local delivery of DOX in order to treat melanoma and prevent its metastasis. (C) 2018 American Institute of Chemical Engineers

Item Type: Article
Keywords: cellulose nanofiber doxorubicin melanoma metastasis gel injectable drug-delivery extracellular-matrix cell invasion tumor-growth cancer chemotherapy hydrogel microparticles nanoparticles inhibition
Subjects: QV Pharmacology
QZ Pathology > QZ 200-380 Neoplasms
Divisions: Faculty of Pharmacy and Pharmaceutical Sciences > Department of Pharmaceutical Biotechnology
Isfahan Pharmaceutical Sciences Research center
Novel Drug Delivery Systems Research Center
Faculty of Pharmacy and Pharmaceutical Sciences > Department of Pharmacotherapy
Page Range: pp. 537-545
Journal or Publication Title: Biotechnology Progress
Journal Index: ISI
Volume: 34
Number: 2
Identification Number: https://doi.org/10.1002/btpr.2598
ISSN: 8756-7938
Depositing User: Zahra Otroj
URI: http://eprints.mui.ac.ir/id/eprint/6457

Actions (login required)

View Item View Item